Who Paid My Doc
Afstyla
Biological Hematology
NDC 69911-477-02
General payments
$339,234
Research payments
$187,620
Through program year 2025, $339,234 in general payments and $187,620 in research payments were reported against Afstyla (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,838 | 115 |
| 2024 | General | $3,132 | 156 |
| 2023 | General | $6,129 | 255 |
| 2022 | General | $7,585 | 229 |
| 2021 | General | $35,716 | 274 |
| 2020 | General | $26,432 | 108 |
| 2020 | Research | $51,960 | 23 |
| 2019 | General | $255,402 | 358 |
| 2019 | Research | $135,660 | 28 |
Breakdown
The top 5 of 92 recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,495 general · 51 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.